Publication Beamlines Strategic Pillar
(2019). Prolactin receptor binding proteins and uses thereof. Patent Number: IL239502B.
(2018). . Patent Number: NO2968312T3.
(2018). Antibody polypeptides that antagonize cd40. Patent Number: IL228720B.
(2018). Methods and compositions. Patent Number: GB201817444D0.
(2018). . Patent Number: NO2699601T3.
(2020). Combination of lif inhibitors and pd-1 axis inhibitors for use in treating cancer. Patent Number: IL277918A.
(2018). Antibody epitope. Patent Number: IL256097A.
(2018). Antibodies to the bradykinin b1 receptor. Patent Number: IL234830B.
(2018). Anti-hemagglutinin antibodies and methods of use. Patent Number: IL263320A.
(2017). ANTI-BCMA ANTIBODIES (CELL MATURATION ANTIGEN B), BINDING SPECIFIC MOLECULES THAT JOIN BCMA AND CD3 (AGGREGATE DETERMINANT 3), AND USES OF THESE. Patent Number: AR105724A1.
(2015). Anti-hemagglutinin antibodies and methods of use. Patent Number: IL238684A0.
(2015). ANTIHEMAGLUTININE ANTIBODIES AND METHODS OF USE. Patent Number: AR093446A1.
(2020). ANTI-BCMA ANTIBODIES, BIESPECIFIC ANTIGEN BINDING MOLECULES THAT BIND BCMA AND CD3, AND THEIR USES. Patent Number: PT3337824T.
(2015). Novel TNFa structure for use in therapy. Patent Number: GB201510758D0.
(2020). Scientific Abstracts and Sessions. Medical Physics 47(6) , E702-E702. 10.1002/mp.14316. BMIT-ID Materials